and daily functioning in individuals with severe, treatment-resistant depression. While the primary outcome measure showed no difference between active and inactive VNS groups, secondary measures ...
A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry. The research, ...